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Summary
Patients with Angelman syndrome (AS) and Prader-Willi
syndrome with mutations in the imprinting process have
biparental inheritance but uniparental DNAmethylation
and gene expression throughout band 15q11-q13. In
several of these patients, microdeletions upstream of the
SNRPN gene have been identified, defining an imprinting
center (IC) that has been hypothesized to control the
imprint switch process in the female and male germlines.
We have now identified two large families (AS-O and
AS-F) segregating an AS imprinting mutation, including
one family originally described in the first genetic linkage
of AS to 15q11-q13. This demonstrates that this original
linkage is for the 15q11-q13 IC. Affected patients in the
AS families have either a 5.5- or a 15-kb microdeletion,
one of which narrowed the shortest region of deletion
overlap to 1.15 kb in all eight cases. This small region
defines a component of the IC involved in AS (ie., the
paternal-to-maternal switch element). The presence of
an inherited imprinting mutation in multiple unaffected
members of these two families, who are at risk for trans-
mitting the mutation to affected children or children of
their daughters, raises important genetic counseling is-
sues.
Introduction
Angelman syndrome (AS) is a neurobehavioral disorder
associated with genomic imprinting in chromosome
15q11-q13, characterized by severe mental retardation,
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lack of speech, ataxic gait, tremulousness, microcephaly,
sleep disorder, and inappropriate laughter (Williams et
al. 1995). AS occurs in ∼1/15,000 births (Clayton-Smith
and Pembrey 1992). AS arises from various genetic ab-
normalities in chromosome 15q11-q13, most commonly
a de novo large cytogenetic deletion of maternal origin,
paternal uniparental disomy (UPD) in rare patients, a
mutation in the imprinting process, or an AS gene mu-
tation (Nicholls et al. 1998). Prader-Willi syndrome
(PWS) is also associated with the imprinted 15q11-q13
region but is clinically distinct and involves large dele-
tions of 15q11-q13, UPD, and imprinting mutations
(IMs) of parental origin opposite that of the similar ge-
netic abnormalities in AS (Nicholls et al. 1998).
Mutations in the imprinting process were first rec-
ognized in AS (Glenn et al. 1993). These patients have
neither the typical deletion nor UPD but show biparental
inheritance with uniparental DNA methylation (Glenn
et al. 1993; Reis et al. 1994; Buiting et al. 1995) and a
uniparental gene expression pattern throughout 15q11-
q13 (Saitoh et al. 1996). The AS IM patients reported
previously include six patients with a microdeletion
(Buiting et al. 1995; Saitoh et al. 1996), one patient with
a putative point mutation (Dittrich et al. 1996) of a
regulatory element termed the “imprinting center” (IC),
and a series of patients without any detectable IC mu-
tation (Buiting et al. 1995, 1998; Bu¨rger et al. 1997).
Linkage of the AS gene to 15q was first suggested in
one large AS family and two small sibships (Wagstaff et
al. 1992, 1993) and by the sharing of maternal haplo-
types in affected AS sibs (Clayton-Smith et al. 1992).
Subsequent linkage analysis confirmed a chromosome
15q locus for AS (Meijers-Heijboer et al. 1992). The
location of the AS gene was refined by use of different-
sized deletions and the positions of translocation break-
points in key patients with AS (Saitoh et al. 1992; Burke
et al. 1996) or in patients lacking AS and having a ma-
ternal deletion in distal 15q11-q13 (Michaelis et al.
1995). The localization was further supported by the
position of genetic crossovers in affected AS sibs (Greger
et al. 1994; Nelen et al. 1994). Subsequently, Kishino et
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al. (1997) identified a gene (UBE3A) broken by a bal-
anced paracentric inversion in an AS patient and dem-
onstrated mutations of UBE3A in additional AS cases,
each leading to frameshifts and premature translation
termination. That mutations in UBE3A could cause AS
was confirmed by the finding of de novo mutations in
two additional AS patients (Matsuura et al. 1997). Sub-
sequent studies have found maternally inherited or de
novo inactivating UBE3A gene mutations in a larger
series of patients with AS (Malzac et al. 1998). Surpris-
ingly, UBE3A mutations were only found in ∼30% of
AS nondeletion, non-UPD, nonimprinting mutation
cases (Malzac et al. 1998), suggesting either that addi-
tional mechanisms can silenceUBE3A or that additional
genes may be involved in AS.
We have restudied the large AS family (AS-O) for
which linkage to 15q11-q13 was first reported, and we
show here that this family has an IM rather than an AS
gene mutation. A small microdeletion of only 5.5 kb is
identified in the AS-O family in this study. The micro-
deletions identified previously in AS IM families defined
a 2-kb shortest region of overlap (SRO) for the deletions.
Abnormalities of this region are sufficient to prevent the
paternal-to-maternal imprint switch by the IC in the ma-
ternal germline (Buiting et al. 1995; Dittrich et al. 1996;
Saitoh et al. 1996; Nicholls et al. 1998). The microde-
letion in the AS-O family narrows the critical region of
the AS IC to 1.15 kb, which will help to define the critical
genetic function of this region. The segregation of an
IM in this large AS family and a larger IC microdeletion
in a second large family (AS-F) has important diagnostic
and genetic counseling consequences.
Patients and Methods
Clinical Phenotype of AS Patients
Two large families (AS-O and AS-F), each with mul-
tiple individuals affected with AS, were ascertained for
this study (fig. 1a and b). Each affected individual has
biparental inheritance for microsatellite markers
throughout 15q11-q13 (fig. 1). The unique structure of
these pedigrees and the small size of genetic aberrations
(see the Results section) allows the possibility of useful
phenotype-genotype correlations, and thus the clinical
features of several affected individuals in each family are
given briefly here.
AS-O Family, Case IV-5.—The patient was born at
term to a G1P0 woman after an uncomplicated pregnancy
with no illness or known teratogenic exposures. Growth
parameters at birth were normal, with birth weight
3,990 g. The perinatal period was uncomplicated. She
was an irritable infant. Global developmental delay was
apparent by 6–8 mo of age, and the patient walked alone
at 2.5 years. At 15 years of age she is able to feed herself
finger foods and to use a fork. She communicates by
using 10–20 signs and two single words that are rec-
ognizable by her family. She is daytime toilet trained by
use of a strict schedule. Her height, weight, and head
circumference have tracked along the 75th percentile.
Pubertal changes were spontaneous and normal, with
onset of menarche at age 14 years. She had strabismus
surgery at the age of 3 years but has otherwise been
healthy. She has never had a documented seizure; how-
ever, an electroencephalogram (EEG) done at the age of
3 years showed a typical pattern seen in children with
AS (Boyd et al. 1988), involving high-voltage 3 cycles/
s runs. She is very active, easily frustrated, and easily
distracted. Problem behaviors include tantrums, pinch-
ing, hitting, and pulling hair. She is frequently awake
and active during the night. The family set up an alarm
system to keep her and her affected sister in the bedroom
they share.
The clinical diagnosis of AS was made when she was
9 years old. Family history revealed a normal and an
affected maternal half sib (case IV-7), as well as male
and female maternal cousins with AS (cases IV-1 and
IV-3; fig. 1a).
Physical examination at age 15 years (fig. 2b) revealed
height at the 75th–90th percentile, weight at the 90th
percentile, and head circumference at the 50th–75th per-
centile. She had abundant head hair and prominent hair
over the temporal aspects of the forehead. She had a flat
midface, a wide-appearing mouth, and mild progna-
thism. There was no scoliosis, heart murmur, or organ-
omegaly. There was bilateral 5th finger clinodactyly. She
had normally pigmented skin and hair. Neurologic find-
ings included drooling, increased tone and deep tendon
reflexes in all extremities, and jerky movements and
hand flapping, both exaggerated with walking. The gait
was broad based and unsteady, with arms held in flexion.
AS-O Family, Case IV-7.—The younger maternal half-
sister of patient IV-5 (fig. 1a) was born at term to a then
G4P2,0,1,2 mother after an uncomplicated pregnancywith-
out known teratogenic exposures. Growth parameters
were normal at birth, with weight 3,975 g, and there
were no problems in the immediate perinatal period. In
the patient’s first weeks of life, her parents recognized
that many of her physical and behavioral characteristics
were similar to those of her oldest sister. She was ex-
tremely irritable and ate poorly. She had persistence of
neonatal reflexes, abnormal tone, and developmental de-
lay, recognized by the age of 4 mo when she had a
persistent startle reflex and continued head lag. AS was
diagnosed on clinical grounds at age 2 years. Herweight,
length, and head circumference have tracked along the
50th percentile. She walked alone at 2.5 years. At 8 years
of age (fig. 2a) she is able to go up and down steps and
to use a fork to feed herself. She babbled at 9–10 mo
but never developed speech. She now uses a few signs.
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Figure 1 Pedigrees of the two AS families. a, AS-O family. b, AS-F family. The chromosome 15q11-q13 haplotype data for the AS-O
family is from Wagstaff et al. (1993), and the haplotype on which the IC mutation arose in each family is boxed.
Her receptive language is better than her expressive lan-
guage. The parents note that she is more likely than her
affected sister to engage and play with other children
and to interact with adults. She uses the toilet on a sched-
ule. Both sisters love to play with toys that make noise.
Her personality is generally pleasant, although she has
significant behavior problems, with temper tantrums and
occasional pinching and pulling hair. Her sleep is ab-
normal, rarely lasting more than 2 h at a time, and she
is awake and playing most nights. She has had no health
problems, nor has she had a seizure.
Physical examination revealed height at the 50th–75th
percentile, weight at the 75th–90th percentile, and head
circumference at the 50th percentile. The head was nor-
mally shaped. There was mild midface hypoplasia. The
teeth were widely spaced, with a mixture of primary and
secondary teeth, and her mandible was prominent. There
was no scoliosis, heart murmur, or organomegaly. She
had normal pigmentation of the skin and hair. Both
hands were small, and she had increased tone in the
extremities and brisk deep tendon reflexes throughout.
Her gait was broad based, with arms held in flexion and
hands flapping.
AS-O Family, Case IV-1.—The patient was examined
at 19 years of age (fig. 2c). Birth weight was 3,890 g.
She has no speech and has severe mental retardation, an
ataxic unsteady gait, a very happy affect, and inappro-
priate laughter. She is affectionate and drools frequently.
She has a high pain threshold, loves playing with water,
and will not wear hats. She has a normal menstrual cycle
and has never had seizures. EEG findings have been nor-
mal. She sleeps only 5–6 h each night. She can ride a
three-wheeled bicycle. She was toilet trained at 8 years.
On physical examination, she was nondysmorphic.
Head circumference was 53 cm (1 SD, whereas the
father was also 1 SD and the mother was 1 SD). She
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Figure 2 Clinical photographs of AS patients. a, b, Maternal
half-sisters. c, Cousin with AS, in the AS-O family. d, e, Affected sibs
in the AS-F family at 6 and 4 years of age.
had moderate obesity. There was no heart murmur or
organomegaly. Breasts and pubic hair were Tanner stage
V. Lordosis was found on spinal examination. She had
genu valgum. Skin pigmentation was normal for the
family. She had typical AS behavior, with easy excita-
bility, hand flapping, very happy affect, no speech, ataxic
gait with uplifted arms, and affectionate behavior with
no stranger anxiety. Deep tendon reflexes were normal
in the upper extremities and mildly increased in the
lower extremities. There was no spasticity.
AS-O Family, Case IV-3.—The patient at the time was
aged 14 years and was described by his two aunts (III-
5 and III-2) as having severe mental retardation, no
speech, a happy affect, inappropriate laughter, easy ex-
citability, and an ataxic gait. In addition, he is a hyper-
active child who sleeps very little and receivesmedication
for his hyperactivity and to help him sleep at night. He
has a high pain threshold and loves playing with water.
He is more aggressive than his cousins (IV-1, IV-5, and
IV-7). He was born after a 37-week gestation and
weighed 2.7 kg.
AS-F Family, Case ASF3.—The proband, a 16-year-old
mentally retarded boy, presentedwithmany features typ-
ical of AS (fig. 2d, at 6 years of age). He was born after
an uneventful pregnancy, with a birth weight of 4,350
g, height of 53 cm, and head circumference of 34 cm.
He had sucking difficulties but an otherwise normal neo-
natal period. His growth has followed the 75th percen-
tile, and his head circumference, the 50th percentile. He
walked unsupported at 18 mo. His gait was ataxic. He
was very restless, day and night. At the age of 3 mo, the
child had staring and “jerking” episodes. He was given
antiepileptic medication at the age of 1.5 years because
of abnormal EEG findings and progressive convulsions.
The epilepsy was classified as Lennox epilepsia and was
treated accordingly. Over time, the convulsions have
ceased, and he is no longer taking antiepileptic medica-
tion.
There are no clear-cut dysmorphic features, but he has
slight telecanthus and a wide mouth, with protruding
tongue, and some drooling. Pigmentation is normal. He
is severely mentally retarded and has very little capacity
for abstract thinking. He is hyperactive but is often in
a happy mood and, at those times, is not restless. His
gait is ataxic but not as severely ataxic as that of his
sister. He cannot speak, except for a few words, but has
become independent with activities of daily life and has
mastered sign language, with 300–350 signs and even
some “sentences.” His behavior includes nail biting and
tearing, and his pain sensitivity is markedly reduced.
AS-F Family, Case ASF4.—The 14-year-old sister (fig.
2e, at 4 years of age) of the proband was born after a
normal pregnancy, with a birth weight of 3,920 g, length
of 51 cm, and head circumference of 35.5 cm. Her neo-
natal findings were normal, but she was seen at the age
of 1 mo for episodes of spasticity. She was also soon
noticed to have “easy and loud laughing.” A protruding
tongue was also noticed, and she was suspected to suffer
from a disorder similar to that of her brother. She also
developed jerky episodes, did not learn to speak, and
showed similar EEG findings. Antiepileptic medication
was started at 1 year of age. She presented with rest-
lessness, slow motor development, clumsiness, and an
ataxic gait. Her growth has followed the 50th percentile,
and her head circumference has been normal. She has a
wide nose bridge with slight telecanthus. Pigmentation
is normal.
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She is somewhat more severely affected than her
brother but is independent in her daily activities. She is
happy and laughs often. She keeps her tongue out of her
mouth and drools. She knows fewer hand signs than
does her brother but is somewhat better in “sentences.”
She can speak a couple of words. She also has reduced
sensitivity to pain and a habit of tearing her nails. She
is somewhat restless, and she discontinued antiepileptic
medication several years ago. Both siblings are fond of
water, plastics, and pictures. Both can use a knife and
fork for eating. Cytogenetic studies showed normal
chromosomes in ASF2, ASF3 and ASF4, whereas FISH
with the D15S10 and PML control probes (Oncor)
showed no deletion in ASF2, ASF3, or ASF4.
The ASF patients’ third cousin, a 4-year-old boy, also
has AS, but he has a del(15)(q12)mat. Furthermore, he
is related to ASF3 and ASF4 through his father.
DNA Extraction, Southern Hybridization, and
Microsatellite Analyses
Blood samples were obtained from AS patients and
parents according to protocols approved by the insti-
tutional review board at each of the relevant institutions.
Many DNA samples from the AS-O family were a kind
gift of Drs. J. Wagstaff and M. Lalande. DNA extraction
from peripheral blood leukocytes and Southern hybrid-
ization with 32P-labeled probes were performed by stan-
dard procedures (Buiting et al. 1995; Glenn et al. 1996),
as was laser densitometry for dosage determination
(Glenn et al. 1993). We used the Y48.5, 1.3XE,
L48.33II, and L48.3I probes from the IC phage contig
for microdeletion analysis as described elsewhere (Buit-
ing et al. 1995; Saitoh et al. 1996). One new IC probe
was developed, kb25XE, a 420-bp XbaI–EcoRV unique
sequence fragment from L48.6I. The L48.3I probe con-
tains repetitive elements and was preassociated with an
excess of human placenta DNA and hybridized under
competitive hybridization conditions, as described else-
where (Buiting et al. 1995). Microsatellite analyses (AS-
F family) were performed by standard techniques, with
markers and PCR conditions from the Genome Data-
base, whereas those for the AS-O family (fig. 1) have
been described elsewhere (Wagstaff et al. 1992, 1993).
DNA Methylation Analyses
DNA was digested with XbaI/NotI, BglII/HpaII
(SNRPN) (Glenn et al. 1996), HindIII/HpaII, or CfoI
(PW71B) (Dittrich et al. 1993) and was analyzed by
Southern analysis. MspI, an isochizomer of HpaII, was
also used for analysis of SNRPN in the AS-F family. The
SNRPN exon 1 (0.6NE, Glenn et al. 1996; or kb17,
Bu¨rger et al. 1997) and PW71B probes were labeled and
hybridized to each membrane, as described above.
IC Polymorphism and Breakpoint Analyses by PCR
After amplification with primers RN747 (5′-GTGA-
AGCGAAGCTCAGACAT-3′) and RN748 (5′-GCTGT-
CCTTGGATATATGCC-3′), which are located in the
1.3XE IC subclone, PCR products were digested with
BstNI for polymorphism analysis. For PCR, conditions
were 94C for 30 s, 58C for 30 s, and 72C for 30 s
(31 cycles). To generate primer sets for breakpoint clon-
ing, we sequenced the microdeletion region (T. Ohta and
R. D. Nicholls, unpublished data), including a 2.1-kb
EcoRI/XbaI fragment subcloned from phage subclone
L48.6I (Buiting et al. 1995), and the L48.8III clone (Buit-
ing et al. 1995). Primers RN307 (5′-TCAAAGGTG-
CACCCTGAGGTCC-3′), within the kb25XE probe,
and RN485 (5′-GGTAACTTACATCCTCTGCTG-3′),
distal to the AS-SRO, were used for long-range PCR to
clone the AS-O breakpoint. Conditions for long-range
PCR were 94C for 30 s, 62C for 30 s, and 72C for
3 min (31 cycles). AS-O family DNA and normal control
DNA were subsequently amplified with primers RN719
(5′-TCTCCAGTGGAGCTCTCTTC-3′) and RN720 (5′-
TGGGTGGCTCACTTTCCTAG-3′), synthesized from
the sequences predicted to flank the AS-O breakpoints
(T. Ohta and R. D. Nicholls, unpublished data). PCR
conditions for the breakpoint PCR were 94C for 30 s,
60C for 30 s, and 72C for 30 s (31 cycles). Control
PCR primers (RN440 and RN441) were from the PWS-
SRO (Ohta et al. 1999 [in this issue]).
Results
DNA Methylation in Two Large AS Families
Probe 0.6NE, containing the SNRPN exon 1 region,
detects allele-specific DNA methylation patterns (Glenn
et al. 1996). The maternal, methylated allele is detected
as a 4.3-kb band, and the paternal, unmethylated allele
is detected as a 0.9-kb band on XbaI/NotI–digested
DNA from normal individuals (fig. 3a, lane 6) and the
mother of the two AS half-sisters (fig. 3a, lane 3). The
parental origin of these alleles is defined by analysis of
PWS and AS control subjects with a paternally or ma-
ternally derived deletion of 15q11-q13, respectively (fig.
3a, lanes 4 and 5). The two affected half-sisters in the
AS-O family (IV-5 and IV-7, fig. 1a) lack the maternal,
methylated 4.3-kb band, which is the typical AS pattern
(fig. 3a, lanes 1 and 2). The intensity of the 0.9-kb band
in IV-5 and IV-7 is twice that of this allele in normal
individuals or in AS or PWS deletion patients, indicating
that two chromosomes 15 are present. The haplotype
analyses with five microsatellite markers (D15S11,
D15S13, D15S97, GABRB3, and GABRA5) that have
been described by Wagstaff et al. (1992, 1993) showed
that these patients do not have UPD and have biparental
inheritance (fig. 1a). Therefore, these two half-sisters
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Figure 3 DNA methylation at SNRPN identifies an imprinting mutation in each AS family. In a, the affected AS-O half-sisters IV-7 (lane
1) and IV-5 (lane 2) have only the unmethylated band after XbaI/NotI digestion of DNA, whereas the mother (III-5) has biparental DNA
methylation. In b, the AS-F family DNA is digested with BglII/HpaII (upper panel) or BglII/MspI (lower panel). HpaII/MspI are isochizomers
that detect a polymorphic site in SNRPN intron 1 (Saitoh et al. 1997), and comparison of the band patterns allows inference of the parental
origin of each band (m or p). See text for further details. mat (m)  maternal; pat (p)  paternal; del  deletion; and N  normal.
have biparental inheritance but a paternal, uniparental
methylation pattern, which is diagnostic of an AS IM.
In the AS-F family, DNA methylation at SNRPN has
been analyzed with BglII/HpaII (fig. 3b). In normal in-
dividuals, a methylated maternal allele is detected as a
2-kb band, whereas the unmethylated paternal allele is
detected as a 0.9- or 0.65-kb band because of a poly-
morphic HpaII/MspI site (Saitoh et al. 1997). Only the
affected ASF3 and ASF4 sibs in the AS-F family show
an abnormal methylation pattern characterized by an
absence of the methylated band, as is typical for AS (fig.
3b, upper panel). On the basis of the HpaII/MspI poly-
morphism (fig. 3b, upper and lower panels), one sib
(ASF3) shows heterozygosity for the SNRPN exon 1
region, indicating that there is no deletion of this region.
The latter analysis can be taken further to infer pa-
rental origin of individual alleles in the AS-F family, by
comparison of the band pattern produced byMspI with
that produced by HpaII (fig. 3b). In normal individuals,
the paternal origin is given by the unmethylated HpaII
allele. For example, ASF8 is homozygous for the 0.9-kb
MspI band, and the 0.9-kb MspI allele inherited from
his father (ASF5) is of grandpaternal origin, since it is
unmethylated on HpaII analysis in ASF5. Similarly,
ASF4 is homozygous for the 0.9-kb MspI band, and the
allele inherited from her mother (ASF2) is of grandpa-
ternal origin, since the 0.9-kb MspI allele in ASF2 is
unmethylated on HpaII analysis. Furthermore, this
methylation analysis shows that the two uncles (ASF7
and ASF8) inherited the same paternal but different ma-
ternal chromosomes. These results are consistent with
the microsatellite analyses (fig. 1b), which also indicate
that both affected sibs inherited the same maternal but
different paternal chromosomes.
The PW71B probe, which maps ∼130 kb upstream of
the SNRPN gene, also detects abnormal DNA methyl-
ation patterns in AS and PWS patients with a deletion,
UPD, or IM (Dittrich et al. 1993; Buiting et al. 1995).
The two affected sibs in the AS-F family had the typical
AS DNA methylation pattern for PW71B, whereas the
father and mother had a normal biparental DNA meth-
ylation pattern (data not shown).
Identification of a 5.5-kb Microdeletion in the AS-O
Family
Some but not all AS patients with an IM have a mi-
crodeletion of the IC region ∼25–30 kb upstream of
SNRPN exon 1 (Buiting et al. 1995, 1998; Saitoh et al.
1996; Bu¨rger et al. 1997). A BstNI polymorphic site in
the region of the IC that is deleted in AS IM cases (fig.
4a) has been identified in the AS-O family and in un-
related individuals (data not shown). This polymor-
phism was assessed in the two half-sisters (IV-5 and IV-
7), mother, and father of IV-7, from the AS-O family.
Patient IV-5 has only the lower (digested) allele, and IV-
7 has only the upper (undigested) allele, the latter in-
herited from her father, who is heterozygous (fig. 4b).
On the basis of the well-establishedmaternal inheritance
pattern in AS (Nicholls et al. 1998), the two affected
patients must share a commonmaternal allele, and there-
fore the results indicate that each patient and the mother
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Figure 4 A 5.5-kb microdeletion of the IC in the AS-O family. a, Molecular map of the AS IC region and extent of the microdeletion
(black bar) in the AS-O family. Open boxes indicate probes and a variable number of tandem repeats (VNTR) sequence (Saitoh et al. 1996);
arrows indicate PCR primers; E  EcoRI; H  HindIII; B  BamHI; and X  XbaI. b, The use of a BstNI restriction fragment length
polymorphism (RFLP) in the IC identifies a deletion in IV-7 and IV-5, since these two half-sisters do not share a visible maternal allele. A 
undigested allele, and B  BstNI-digested allele. c, The L48.3I probe detects the distal breakpoint in BamHI-digested DNA. d, The kb25XE
probe detects the proximal breakpoint in BamHI-digested DNA.
are most likely hemizygous for the IC region. In other
words, this analysis predicts that the maternal allele is
deleted, identifying an IC microdeletion in the AS-O
family.
To confirm and define the extent of the IC microde-
letion in the AS-O family, we performed Southern anal-
yses with probes from the IC (fig. 4a). To date, all distal
breakpoints in AS IM cases cluster in the region detected
by the L48.6I to L48.3I probes (Buiting et al. 1995;
Saitoh et al. 1996), and therefore these probes were an-
alyzed initially. The L48.3I probe detected bands of 15
and 8 kb on BamHI digestion in the normal control, the
AS deletion control, and the IV-5 AS patient, with an
additional 9.5-kb band in the AS-O patient IV-5 only
(fig. 4c). The 15-kb BamHI band showed a 50% re-
duction in intensity in the AS IM patient IV-5 (fig. 4c),
but the intensity of the 8-kb band was normal. The
L48.3I probe did not detect an extra band or reduced
intensity on EcoRI digestion, whereas probe 1.3XE
showed a 50% reduction in signal on both EcoRI and
BamHI digestion (data not shown). These results indi-
cate that the IV-5 AS patient has a deletion in the 1.3XE
region with a distal breakpoint inside the 15-kb BamHI
fragment.
To define the proximal extent of the microdeletion,
probe Y48.5, which maps further proximal, was ex-
amined but was not deleted in the AS IV-5 patient (data
not shown). Probe kb25XE was examined next and is
located at the proximal end of the 15-kb BamHI frag-
ment detected by the L48.3I and 1.3XE probes (fig. 4a).
In BamHI-digested DNA, this probe detected the normal
15-kb band in control DNA and in an AS deletion con-
trol, but was of reduced intensity, and also detected the
9.5-kb breakpoint band in the AS-O (IV-5) patient (fig.
4d). The kb25XE probe also detects the breakpoint band
in XbaI digested DNA from the IV-5 AS patient (data
not shown). Taken together, these data indicate that the
AS-O affected patient IV-5 has a 5.5-kb microdeletion
of the IC (fig. 4a).
Breakpoint PCR Analysis in the AS-O Family
The breakpoint of the IC microdeletion in the AS-O
patient IV-5 was identified by long-range PCR with
primers RN307 and RN485 (fig. 4a), in which a unique
1,360-bp band was present in the affected patient (IV-
5), but not in the controls, and this fragment was cloned
and sequenced (T. Ohta and R. D. Nicholls, unpublished
data). From this sequence, we developed a proximal
primer RN719 and used this with primer RN720 from
the distal end of the microdeletion region, to amplify a
microdeletion-specific PCR product in the AS-O IV-5
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Figure 5 PCR breakpoint analysis of an IC microdeletion in the AS-O family. PCR with primers RN719 and RN720 (upper panel)
identifies a breakpoint-specific fragment only in II-1, III-2, IV-1, III-4, IV-3, III-5, IV-5, IV-7, and III-9 in the AS-O family. The use of control
primers (PWS-SRO) for PCR shows amplification in all DNA samples (lower panel).
and IV-7 patients, but not in the controls (fig. 5 and data
not shown). We then analyzed all relevant members of
the large AS-O family (fig. 1a) using these breakpoint-
specific primers. PCR of II-1, III-2, III-4, III-5, III-9, IV-
1, IV-3, IV-5, and IV-7 genomic DNA showed a positive
breakpoint-PCR product, whereas PCR of II-2, III-1, III-
3, III-6, III-7, III-8, IV-2, IV-4, IV-6, IV-8, and IV-9 in-
dividuals showed no amplification (fig. 5, upper panel).
These results are 100% concordant with haplotype stud-
ies in this family reported byWagstaff et al. (1992, 1993;
fig. 1a). Control primers from the PWS-SRO part of the
IC (fig. 6) showed PCR products from all individuals in
the AS-O family (fig. 5, lower panel).
Identification of a 19-kb Microdeletion in the AS-F
Family
Using probe kb25XE (fig. 4a), we detected an abnor-
mal EcoRI fragment of 6.2 kb (data not shown). No
abnormal EcoRI fragment could be identified with sev-
eral probes that included a PCR probe for the AS-SRO
(primers RN285  IC3), L48.3I, L48.3p1p2  l48.3P
(both subfragments for L48.3I), or L48.33II. For the AS-
SRO and L48.3I probes, dosage analyses showed a re-
duction of intensity to 50%, indicating a deletion (data
not shown). In KpnI digested DNA, an abnormal frag-
ment of ∼14 kb was detected with kb25XE in both af-
fected sibs, the mother, two uncles, and the grandfather
(fig. 7, upper panel). By using the 3-kb L48.33II EcoRI
fragment as a probe, we identified the same KpnI junc-
tion fragment (fig. 7, lower panel). On the basis of these
data, the proximal breakpoint must lie in the 6.8-kb
L48.6I EcoRI fragment, the distal breakpoint in the
L48.33II EcoRI fragment, and the size of the deletion is
estimated at ∼19 kb (fig. 6). The extent of the new mi-
crodeletions in the AS-O and AS-F families, and the re-
lationship of these to previously identified cases, are
summarized in figure 6.
Discussion
We have identified an inherited IM in each of two
large AS families, including one originally reported as
the first linkage evidence for an AS gene in 15q11-q13
(Wagstaff et al. 1992, 1993). The finding of an IC mu-
tation in the AS-O family indicates that the initial linkage
was for the AS component of the IC to 15q11-q13,
rather than to a specific AS gene. IMs were unknown at
the time that the initial linkage studies were performed
(Wagstaff et al. 1992, 1993), and, therefore, a putative
AS gene mutation was the only available hypothesis at
that time. Subsequently, an AS gene was identified in
15q11-q13 with the finding of mutations in the UBE3A
gene in nondeletion, non-UPD, non-IM AS patients
(Kishino et al. 1997; Matsuura et al. 1997; Malzac et
al. 1998). Initial molecular diagnosis in a clinical lab-
oratory setting for the AS-O family reportedly used the
PW71B probe, and we showed recently that DNAmeth-
ylation with this probe in some AS IM patients indicates
the presence of both methylated (maternal) and unme-
thylated (paternal) bands, albeit the former is reduced
in intensity compared to normals, rather than only the
unmethylated band typical of AS deletion and UPD pa-
tients (Saitoh et al. 1997). As shown here, the SNRPN
DNA methylation probe clearly identified an imprinting
mutation in the AS-O and AS-F families as well as in
other IM families (Buiting et al. 1995; Saitoh et al. 1996,
1997). However, we urge caution in the diagnostic in-
terpretation for methylation with any probe if the meth-
ylated and unmethylated alleles do not show an equi-
molar ratio, since such a result may be indicative of an
IM, and we recommend further investigation to examine
this possibility.
Previously, we detected microdeletions in six AS fam-
ilies with an IM (Buiting et al. 1995; Saitoh et al. 1996).
These cases share a 2-kb SRO ∼25-30 kb upstream of
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Figure 6 Summary map of AS microdeletions in the IC and minimal definition of the AS-SRO. The extent of deletions in the new AS
families AS-O and AS-F are compared to six previously published deletions (Buiting et al. 1995; Saitoh et al. 1996). The vertical arrow identifies
a point mutation in the splice donor site of the IC transcript exon 2, in family AS-C2 (Dittrich et al. 1996). The location of the PWS-SRO is
also shown (Buiting et al. 1995; Ohta et al. 1999 [in this issue]). Microdeletions in AS families affect the paternal-to-maternal (patrmat) switch
in the female germline and microdeletions in PWS families affect the maternal-to-paternal (matrpat) switch in the male germline. Upper
blackened boxes indicate exons, and lower blackened boxes and thin horizontal lines indicate DNA probes.
Figure 7 A 19-kb microdeletion of the IC in the AS-F family.
The kb25XE probe detects the proximal breakpoint in KpnI-digested
DNA (upper panel), whereas the L48.33II probe detects the distal
breakpoint in KpnI-digested DNA (lower panel).
the SNRPN promoter region (Saitoh et al. 1996). In the
present study, the distal breakpoint of the 5.5-kb mi-
crodeletion in the AS-O family is located 800 bp prox-
imal of the previously identified AS-SRO distal end.
Therefore, the new AS-SRO is narrowed to a 1.15-kb
region (fig. 6), and deletion of this 1.15-kb region alone
may be sufficient to prevent the paternal-to-maternal
imprint switch in the female germline (Nicholls et al.
1998). Nevertheless, either identification of such a de-
letion in an AS patient or development of animal models
will be necessary to confirm this suggestion. DNA se-
quence analysis of the AS-SRO region (T. Ohta, S. Sai-
toh, K. Buiting, B. Horsthemke, and R. D. Nicholls,
unpublished data) demonstrates no obvious features that
may suggest an explanation of the molecular basis for
the effect of mutations in this region. Previously, we
identified a novel alternative 5′ transcript of the SNRPN
gene (Dittrich et al. 1996), also termed the “IC tran-
script” on the basis of its candidacy for the imprinting
control element involved in the paternal-to-maternal im-
print switch (Nicholls et al. 1998). Exon 3 of the IC
transcript is deleted in seven AS IM patients, including
the present patients, and a point mutation in the splice
donor site of exon 2 was also detected in a single AS
IM patient (fig. 6; Dittrich et al. 1996). Nevertheless,
the AS-H 6-kb microdeletion and the AS-SRO do not
include the IC transcript exon 3, suggesting that the AS-
SRO encodes another genetic element. This may be a
novel exon of the IC transcript (C. Fa¨rber, B. Dittrich,
K. Buiting, and B. Horsthemke, unpublished data), a
transcriptional or splice enhancer for the IC transcript,
or a binding site for a trans-acting factor involved in the
imprint switch process (reviewed in Nicholls et al. 1998).
Intriguingly, the IC region showing specific mutations
in AS IM patients maps ∼250–500 kb upstream of the
UBE3A structural gene (Kishino et al. 1997; Nicholls
1998), which is mutated in a different class of AS pa-
tients (Kishino et al. 1997; Matsuura et al. 1997). The
IC has been shown to be involved in the parental imprint
switch of all imprinted genes over the 2-Mb imprinted
domain in 15q11-q13 (Buiting et al. 1995; Dittrich et
al. 1996; Saitoh et al. 1996; Nicholls et al. 1998), in-
cluding paternal-only and maternal-only expressed
genes. Therefore, AS sporadic and familial patients can
have specific mutations in two genetic elements located
at a significant distance from each other, either a cis
regulatory sequence that acts in the germline (the IC) or
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in a structural gene (UBE3A) important for proper brain
development and function.
The AS gene,UBE3A, encodes an E3 ubiquitin protein
ligase likely to be involved in protein degradation path-
ways (Huibregtse et al. 1993; Scheffner et al. 1995;
Hochstrasser 1996). Recently, evidence has been re-
ported for tissue-specific imprinting ofUBE3A,withma-
ternal-only expression in human brain (Rougeulle et al.
1997; Vu and Hoffman 1997). Expression of the mouse
Ube3a gene is also maternal-only in cerebellar Purkinje
cells, hippocampal neurons, and mitral cells of the ol-
factory bulb (Albrecht et al. 1997). Similarly, evidence
for maternal-only Ube3a expression in mouse cerebel-
lum and hippocampus has been obtained by analysis of
an inherited deletion of this gene (K. C. Goss, J. Schryver,
M. Dhar, R. D. Nicholls, E. M. Rinchik, and D. K.
Johnson, unpublished data) or a gene knockout (Jiang
et al. 1998). Although the parental-specific expression
of the UBE3A gene in brain might be controlled by a
differentially regulated promoter (Kishino et al. 1997)
or enhancer (Tilghman et al. 1998; see Schumacher et
al. 1998 for evidence against this proposal) or by dif-
ferential splicing (Yamamoto et al. 1997), evidence sug-
gests that the most likely explanation is inhibition of
paternal allele expression by antisense gene regulation
(Nicholls et al. 1998; Rougeulle et al. 1998). The AS-
SRO in the 1.15-kb IC region may therefore be proposed
to act through setting the gamete-specific epigenetic
mark at the oppositely imprinted antisense gene rather
than directly at UBE3A itself. Similarly, the IC controls
the gametic methylation mark of the paternally ex-
pressed SNRPN (Glenn et al. 1996) and ZNF127 (Jong
et al., in press) genes.
Interestingly, in the AS-F family, a paternal cousin also
has AS as a consequence of a maternal 15q11-q13 de-
letion. A similar finding of maternal 15q11-q13 dele-
tions in affected AS cousins, related through the fathers,
was recently made in two pedigrees (Connerton-Moyer
et al. 1997). These findings are consistent with an AS
frequency of ∼1/15,000 births and likely occur by chance
(Connerton-Moyer et al. 1997).
All four affected AS individuals in the AS-O family
and the two AS sibs in the AS-F family meet the clinical
criteria for AS (Williams et al. 1995), with severe mental
retardation, severe speech impairment, ataxic gait, and
typical AS behavior, including an inappropriately happy
affect, sleep disturbance, and easy excitability, with hand
flapping. However, several features distinguish these in-
dividuals from the classic AS deletion patients, including
the lack of seizures in several individuals and milder
seizures in the others, absence of microcephaly, larger
birth size and more body and muscle mass, better fine
and gross motor control, and normal pigmentation.
These differences may arise because genes subject to hap-
loinsufficiency may contribute to the AS phenotype in
deletion patients (Minassian et al. 1998; Nicholls 1998),
or IM patients (and UPD) may be milder as a conse-
quence of theUBE3A gene showing incomplete imprint-
ing in brain (Albrecht et al. 1997; Rougeulle et al. 1997;
Vu and Hoffman 1997), and thus they would have a
double dose of paternal allelic expression of this gene.
Analyses in these large families may also allow appre-
ciation for the intrafamilial variability in the clinical phe-
notype produced by the same mutation in different in-
dividuals, particularly in the neurologic and behavioral
aspects. In the AS-O and AS-F IM families, the affected
siblings do not differ significantly in the severity of their
AS features, apart from some differences in aggressive-
ness, ataxia, and hyperactivity. In contrast, we previ-
ously described one AS IM family (AS-H) in which the
two siblings’ conditions differed significantly in severity
(Saitoh et al. 1997). The clinical differences in these cases
may be caused by genetic background effects or by sto-
chastic differences in imprinted or developmental gene
expression.
Our molecular results allow explanation of the in-
heritance patterns in these large AS families. In the AS-
O family, the grandfather (II-1) has the same microde-
letion as the patients, in his leukocyte DNA. His sisters
(II-4, II-5, and II-10) and brother (II-7) also inherited
the same great-grandpaternal haplotype (fig. 1a; Wags-
taff et al. 1993), but no microdeletion was detected in
these individuals in our microdeletion-specific PCRassay
(data not shown; results of breakpoint-specific PCRwere
also negative in brothers II-8 and II-9). These results
therefore directly confirm the previous prediction (Wags-
taff et al. 1993) that the mutation must have arisen as
a de novo event on the J2EJD haplotype in the germline
of I-1 (fig. 1a). This mutational event must have occurred
after setting of the paternal imprint, and thus a paternal
epigenotype was fixed on the allele (Nicholls et al. 1998).
Individuals III-2, III-4, III-5, and III-9 inherited the mu-
tated allele from their father (II-1), but their phenotype
is normal because of inheritance of a biparental epigen-
otype. In the female germline of III-2, III-4, and III-5,
the paternal epigenotype cannot be reset into a maternal
imprint, because of the IC mutation. Therefore, the pa-
tients have biparental inheritance but a uniparental pa-
ternal imprinted epigenotype.
The presence of an inherited IM in multiple unaffected
members of the AS-O and AS-F families, who are at risk
of transmitting the mutation to their children or to the
children of their daughters, raises important genetic
counseling issues. Individual III-9, in the AS-O family,
and individuals ASF7 and ASF8, in the AS-F family, are
male carriers of the IC mutation. In our IM inheritance
model (Nicholls et al. 1998), silent transmission occurs
whenever offspring are of the same sex as the transmit-
ting ancestor in whom the epigenotype was first fixed,
because of inheritance of biparental imprints in such
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individuals. In AS families, paternal transmission occurs
silently, as explained above. Thus, the children of these
male carriers in the AS-O and AS-F families will have a
normal phenotype, but they have a 50% risk of being
a carrier of the IC mutation. Male offspring who are
carriers of the mutation similarly have a 50% chance of
transmitting the mutation silently, but female offspring
who are carriers have a 50% risk of having children
who inherit the mutation and hence develop the AS phe-
notype (because of maternal inheritance of a paternal
epigenotype).
In such IM families, all individuals at risk for carrier
status should be offered molecular testing and genetic
counseling. Prenatal diagnosis is possible and genetic
counseling is recommended for those individuals who
are at risk for having a child with AS. Such families
present a real challenge to the genetic counselor, since
carrier males are not at risk for having a child with AS,
but their daughters have a 50% risk of inheriting the
mutation and their grandchildren have a 25% risk of
having AS. Similar considerations also theoretically oc-
cur for PWS IM families, although the parental origins
are opposite those described here for AS.We recommend
that such individuals and families obtain genetic coun-
seling, which would include explanation of the patterns
of inheritance and discussion of (1) the possibility of “at
risk” molecular genetic testing specific to each family,
(2) the availability of services of a molecular laboratory
familiar with IC analysis (because this is a difficult region
to analyze), and (3) the importance of careful consid-
eration of possible genetic options, including appropri-
ate reproductive choices.
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